Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter C Smits

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Circulation|September 1, 2024
Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-AnalysisGianluca Campo, Felix Böhm, Thomas Engstrøm, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 4, 2025
Abbreviated or standard antiplatelet therapy after PCI in HBR patients with chronic kidney disease: a prespecified analysis from the MASTER DAPT trialAntonio Landi, Felix Mahfoud, Enrico Frigoli, et al.
Circulation|August 9, 2006
Multislice spiral computed tomography for the evaluation of stent patency after left main coronary artery stenting: a comparison with conventional coronary angiography and intravascular ultrasoundCarlos A G Van Mieghem, Filippo Cademartiri, Nico R Mollet, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER IIIPhilippe Garot, Martin B Leon, Shigeru Saito, et al.
The New England Journal of Medicine|September 1, 2025
Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial InfarctionGiuseppe Tarantini, Benjamin Honton, Valeria Paradies, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 1, 2013
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trialsBill D Gogas, Christos V Bourantas, Hector M Garcia-Garcia, et al.
Circulation|August 11, 2017
Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis)David E Kandzari, Pieter C Smits, Michael P Love, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 16, 2026
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trialPieter C Smits, Adrian Włodarczak, Bernard Chevalier, et al.
European Heart Journal|May 17, 2022
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysisMarco Valgimigli, Pieter C Smits, Enrico Frigoli, et al.
Circulation|April 6, 2021
Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical TrialAlexandra J Lansky, Dean J Kereiakes, Andreas Baumbach, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Circulation|September 1, 2024
Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-AnalysisGianluca Campo, Felix Böhm, Thomas Engstrøm, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 4, 2025
Abbreviated or standard antiplatelet therapy after PCI in HBR patients with chronic kidney disease: a prespecified analysis from the MASTER DAPT trialAntonio Landi, Felix Mahfoud, Enrico Frigoli, et al.
Circulation|August 9, 2006
Multislice spiral computed tomography for the evaluation of stent patency after left main coronary artery stenting: a comparison with conventional coronary angiography and intravascular ultrasoundCarlos A G Van Mieghem, Filippo Cademartiri, Nico R Mollet, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER IIIPhilippe Garot, Martin B Leon, Shigeru Saito, et al.
The New England Journal of Medicine|September 1, 2025
Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial InfarctionGiuseppe Tarantini, Benjamin Honton, Valeria Paradies, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 1, 2013
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trialsBill D Gogas, Christos V Bourantas, Hector M Garcia-Garcia, et al.
Circulation|August 11, 2017
Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis)David E Kandzari, Pieter C Smits, Michael P Love, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 16, 2026
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trialPieter C Smits, Adrian Włodarczak, Bernard Chevalier, et al.
European Heart Journal|May 17, 2022
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysisMarco Valgimigli, Pieter C Smits, Enrico Frigoli, et al.
Circulation|April 6, 2021
Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical TrialAlexandra J Lansky, Dean J Kereiakes, Andreas Baumbach, et al.
Pageof 19